Clinical Trials in Ohio

Showing 9361-9380 of 20,938 trials

Integrated Second Language Learning for Chronic Care

NCT02864160

Language barriers continue to impede access to quality care for limited English proficient populations. Recent research has demonstrated that access to language concordant providers increases quality of care. This project evaluates the efficacy and acceptability of a model intervention to improve second language proficiency, patient-centered communication, and clinical competency of nurse practitioner students who care for Spanish-speaking patients with diabetes.

Diabetes Mellitus

Ohio State University64 participantsStarted Sep 2014

Tucson, Arizona, United States • Columbus, Ohio, United States

COMPLETEDPhase 332 miles

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

NCT03759392

The purpose of this study is to evaluate the effect of treatment with omecamtiv mecarbil compared with placebo on exercise capacity as determined by cardiopulmonary exercise testing following 20 weeks of treatment with omecamtiv mecarbil or placebo

Heart Failure With Reduced Ejection Fraction

Cytokinetics276 participantsStarted Apr 2019

Anchorage, Alaska, United States • Little Rock, Arkansas, United States • Torrance, California, United States +78 more locations

Integrated Second Language Learning for Chronic Care

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

Find Trials by Condition in Ohio

An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)

A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy

A Safety Study of SGN-LIV1A in Breast Cancer Patients

A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Bacteriophage Therapy in Patients With Urinary Tract Infections

A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge

Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B

A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

Achieving Diagnostic Excellence Through Prevention and Teamwork

Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors